Back
Laurent-Perrier Vs. Cidara Therapeutics Industry Stock Comparison
Sell
34
LPRRF
Laurent-Perrier
Last Price:
$134.40
Seasonality Move:
1.78%
Buy
72
CDTX
Cidara Therapeutics
Last Price:
$50.58
Seasonality Move:
-8.55%
Sell
34
Laurent-Perrier (LPRRF)
is a Sell
Is Laurent-Perrier a Buy, Sell or Hold?
-
The current Laurent-Perrier [LPRRF] share price is $134.40. The Score for LPRRF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
LPRRF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.54. The Score for CDTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LPRRF Stock Price Chart
What is Laurent-Perrier's stock price today?
-
The Laurent-Perrier share price today is $134.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LPRRF is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
LPRRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 29.89 | Buy |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (134.4 - 134.4) | Sell |
Bollinger Bands (100): | (134.4 - 134.4) | Sell |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.75 | Buy |
Relative Strength Index (14 RSI): | 77.36 | Buy |
Chaikin Money Flow: | 24640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.19 - 50.39) | Buy |
Bollinger Bands (100): | (16 - 35.28) | Buy |
LPRRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 134.4 | Sell |
20-day SMA: | 134.4 | Sell |
50-day SMA: | 134.4 | Sell |
200-day SMA: | 134.4 | Sell |
8-day EMA: | 85.22 | Buy |
20-day EMA: | 44.34 | Buy |
50-day EMA: | 19.87 | Buy |
200-day EMA: | 5.27 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.6 | Buy |
20-day SMA: | 40.9 | Buy |
50-day SMA: | 30.03 | Buy |
200-day SMA: | 21.62 | Buy |
8-day EMA: | 49.1 | Buy |
20-day EMA: | 42.88 | Buy |
50-day EMA: | 33.88 | Buy |
200-day EMA: | 23.66 | Buy |
Laurent-Perrier Earnings Growth & LPRRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Laurent-Perrier Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |